Subscribe or Manage Preferences
Although the National Practitioners Data Bank (NPDB) could have a potentially vast impact on any healthcare practitioner’s career, few fully understand its setup, its implications, or what to do if they are reported to this electronic repository. The NPDB was [ Read More ]
As we know, the American healthcare system is going through exorbitant changes, changes that will affect all providers and all stakeholders in the cancer care ecosystem. The goal of the Association for Value-Based Cancer Care (AVBCC) is to bring together [ Read More ]
Health plans and oncology practices alike are evaluating the use of specialty pharmacy as a resource for the delivery of cancer drugs. Specialty pharmacy organizations are creating large divisions to manage oncology spending and to provide not only oral drugs [ Read More ]
Politics makes extreme messes. While Congress and the administration continue their political lunging and feinting (not to mention grandstanding), cancer care providers are hunkering down, buying drugs, and caring for patients with cancer. Here is our biggest challenge: the looming [ Read More ]
On January 18, 2013, nearly 3 years after its initial proposed rule, the US Department of Health and Human Services (HHS) issued the long-awaited and much-anticipated HIPAA “omnibus” rule, extending the scope of the privacy law beyond providers to their [ Read More ]
Since 2004, un?der the False Claims Act, whistleblowers have fueled numerous federal investigations into fraudulent claims for reimbursement from federal programs, such as Medicare, that violated the Food, Drug, & Cosmetic (FD&C) Act. But now the long-held understanding that a [ Read More ]
The following sections will assist healthcare professionals and payers by providing appropriate coding and billing information associated with the treatment of multiple myeloma. The following sections include: Associated ICD-9-CM codes used for the classification of multiple myeloma Drugs that have [ Read More ]
Although it has been around since 1998 and is one of the best financial tools available, most oncologists, as high-income taxpayers, were unable to take advantage of the Roth IRA because of income limitations. However, as of January 1, 2010, [ Read More ]